Immune Checkpoints Inhibitors and SRS/SBRT Synergy in Metastatic Non-Small-Cell Lung Cancer and Melanoma: A Systematic Review

Background: Several immunotherapy (IT) agents are FDA approved for treatment of melanoma and non-small-cell lung cancer (NSCLC). The addition of stereotactic radiosurgery (SRS) or stereotactic body radiation therapy (SBRT) to immunotherapy looks promising. A systematic review was conducted to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez Plá, María, Dualde Beltrán, Diego, Ferrer Albiach, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584181/
https://www.ncbi.nlm.nih.gov/pubmed/34769050
http://dx.doi.org/10.3390/ijms222111621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584181/
https://www.ncbi.nlm.nih.gov/pubmed/34769050
http://dx.doi.org/10.3390/ijms222111621

Ejemplares similares